196 related articles for article (PubMed ID: 11180079)
1. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors.
Kokawa A; Kondo H; Gotoda T; Ono H; Saito D; Nakadaira S; Kosuge T; Yoshida S
Cancer; 2001 Jan; 91(2):333-8. PubMed ID: 11180079
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors.
Koshiba T; Hosotani R; Miyamoto Y; Wada M; Lee JU; Fujimoto K; Tsuji S; Nakajima S; Doi R; Imamura M
Int J Pancreatol; 1999 Oct; 26(2):69-76. PubMed ID: 10597402
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
[TBL] [Abstract][Full Text] [Related]
4. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ
Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
Wang HX; Chen QK
Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
[TBL] [Abstract][Full Text] [Related]
7. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
Merati K; said Siadaty M; Andea A; Sarkar F; Ben-Josef E; Mohammad R; Philip P; Shields AF; Vaitkevicius V; Grignon DJ; Adsay NV
Am J Clin Oncol; 2001 Oct; 24(5):447-52. PubMed ID: 11586094
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
9. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
[TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
[TBL] [Abstract][Full Text] [Related]
13. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
14. COX-2 inhibition in clinical cancer prevention.
Lynch PM
Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):21-6. PubMed ID: 11301836
[TBL] [Abstract][Full Text] [Related]
15. COX-2 in large bowel cancer: a one-sided story.
DuBOIS RN
Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
[No Abstract] [Full Text] [Related]
16. The role of COX-2 in intestinal cancer.
Williams C; Shattuck-Brandt RL; DuBois RN
Ann N Y Acad Sci; 1999; 889():72-83. PubMed ID: 10668484
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
[TBL] [Abstract][Full Text] [Related]
18. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
[TBL] [Abstract][Full Text] [Related]
19. A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
Furukawa F; Nishikawa A; Lee IS; Kanki K; Umemura T; Okazaki K; Kawamori T; Wakabayashi K; Hirose M
Int J Cancer; 2003 Apr; 104(3):269-73. PubMed ID: 12569549
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer.
Franco L; Doria D; Bertazzoni E; Benini A; Bassi C
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):51-8. PubMed ID: 15165031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
